Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer

Clinical trial NCT02560298 · UNKNOWN

Trial details

NCT number: NCT02560298
Sponsor: ECOG-ACRIN Cancer Research Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Anal Basaloid Carcinoma Anal Canal Cloacogenic Carcinoma Anal Squamous Cell Carcinoma Metastatic Anal Canal Carcinoma Recurrent Anal Canal Carcinoma Stage IIIB Anal Canal Cancer Stage IV Anal Canal Cancer

Start date: 2016-08-23
Primary completion: 2021-08-31
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.